Avonex (Interferon-Beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-Remitting MS

This study is ongoing, but not recruiting participants.

Study NCT00168766 Information provided by Biogen Idec

First Received: September 13, 2005 Last Updated: December 20, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	November 2008
Estimated Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)